Back to search

High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

Data up to Jan 2025

Published2003
Citations403
References29
Clinical Trials (1)

Total Citations Per Year

Abstract

References (29)

Acute-Phase Proteins and Other Systemic Responses to Inflammation

1999 • 6,324 citations

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

2001 • 2,473 citations

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1994 • 2,343 citations

Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

2000 • 1,945 citations

Effect of Statin Therapy on C-Reactive Protein Levels

2001 • 1,627 citations

Current Concepts of the Pathogenesis of the Acute Coronary Syndromes

2001 • 1,568 citations

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

2001 • 1,537 citations

Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

2000 • 1,220 citations

A Self-Fulfilling Prophecy

2002 • 1,039 citations

Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques

2001 • 995 citations

Stability and Instability: Two Faces of Coronary Atherosclerosis

1996 • 910 citations

Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells

2002 • 854 citations

C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

1998 • 788 citations

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

2001 • 783 citations

Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

2001 • 758 citations

Elevated Levels of Interleukin-6 in Unstable Angina

1996 • 744 citations

An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro

2001 • 597 citations

Elevation of C-reactive protein in “active” coronary artery disease

1990 • 592 citations

C-Reactive Protein in the Arterial Intima

2000 • 590 citations

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol

2002 • 557 citations

Absence of Diurnal Variation of C-Reactive Protein Concentrations in Healthy Human Subjects

2001 • 402 citations

Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death

2002 • 364 citations

T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes

2002 • 361 citations

Myocardial injury: The acute phase response and lipoprotein metabolism

1993 • 275 citations

C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas.

1987 • 164 citations

Enhanced inflammatory response in patients with preinfarction unstable angina

1999 • 155 citations

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

2002 • 149 citations

Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia

2002 • 75 citations

Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques.

1999 • 57 citations

Cited By (0)

Loading...